VR

Venkatapratap Reddy Manne

Active Director Director DIN 09724557
DIN 09724557 First appointment Sep 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkatapratap Reddy Manne

Data last updated:

Venkatapratap Reddy Manne is a Director at Dr Mrm Laboratories Private Limited (since 2022). The company operates in Pharma.

DIN 09724557
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dr Mrm Laboratories Private Limited U24290TG2022PTC166266
Director01 Sep 20222022Active

Board colleagues of Venkatapratap Reddy Manne

NameDINCompanyDesignation
Manne Madhava Reddy09724556Dr Mrm Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr Mrm Laboratories Private Limited
Premium access

Shareholding and investment profile for Venkatapratap Reddy Manne

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatapratap Reddy Manne

Venkatapratap Reddy Manne currently holds 1 directorship: Dr Mrm Laboratories Private Limited (Director, since 01 Sep 2022).

Venkatapratap Reddy Manne was first appointed on 01 Sep 2022 as Director at Dr Mrm Laboratories Private Limited.

The current boards of Venkatapratap Reddy Manne's companies include Manne Madhava Reddy (Dr Mrm Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available